Why the study?
Does new permanent pacemaker implantation within 30 days following TAVR increase mortality or heart failure rehospitalization in patients undergoing TAVR?
Does new permanent pacemaker implantation within 30 days following TAVR increase mortality or heart failure rehospitalization in patients undergoing TAVR?
Answers are grounded in this paper and cite their sources.
New permanent pacemaker implantation after TAVR does not increase mortality but is associated with increased heart failure rehospitalization and impaired LVEF recovery.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: